Iradimed Corp (IRMD)
Share
☆ Add to watchlist
$83.45
▼ −1.64%
LAST CLOSE · NOV 17
IRADIMED makes MRI compatible IV infusion pumps and patient vital signs monitors for hospitals and acute care facilities. It last closed at $83.45 on Nov 17, down 1.64% on the day. IRMD reports earnings on Tue, Feb 9, 2027.
Read more
Key Stats Earnings Whale Flow Institutional AI Auto Pilots Market News About
Key Stats Last 12 months Results
Revenue
$89.3M
+11.0% vs a year ago
Net income
$24.0M
+13.2% vs a year ago
EPS (diluted)
$1.87
+13.3% vs a year ago
Free cash flow
$26.1M
29.3% margin
Valuation
Market cap
$1.1B
12.8M shares
P/E
44.6
Price over 12 month EPS
Price to sales
11.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$63.3M
At Sep 30
Shareholder equity
$106.5M
Shares outstanding
12.8M
At Oct 30
Fiscal year ends December
Exchange Nasdaq
Financials history
Revenue Net income Free cash flow
Annual Quarterly
FY2021: $41.8M $41.8M FY2021 FY2022: $53.3M $53.3M FY2022 FY2023: $65.6M $65.6M FY2023 FY2024: $73.2M $73.2M FY2024 FY2025: $83.8M $83.8M FY2025
FY2021: $9.3M $9.3M FY2021 FY2022: $12.8M $12.8M FY2022 FY2023: $17.2M $17.2M FY2023 FY2024: $19.2M $19.2M FY2024 FY2025: $22.5M $22.5M FY2025
FY2021: $10.8M $10.8M FY2021 FY2022: $9.2M $9.2M FY2022 FY2023: $6.0M $6.0M FY2023 FY2024: $17.6M $17.6M FY2024 FY2025: $17.2M $17.2M FY2025
Dec ’24: $19.4M $19.4M Dec ’24 Mar ’25: $19.5M $19.5M Mar ’25 Jun ’25: $20.4M $20.4M Jun ’25 Sep ’25: $21.2M $21.2M Sep ’25 Dec ’25: $22.7M $22.7M Dec ’25 Mar ’26: $22.0M $22.0M Mar ’26 Jun ’26: $20.5M $20.5M Jun ’26 Sep ’26: $24.2M $24.2M Sep ’26
Dec ’24: $5.1M $5.1M Dec ’24 Mar ’25: $4.7M $4.7M Mar ’25 Jun ’25: $5.8M $5.8M Jun ’25 Sep ’25: $5.6M $5.6M Sep ’25 Dec ’25: $6.4M $6.4M Dec ’25 Mar ’26: $5.8M $5.8M Mar ’26 Jun ’26: $5.2M $5.2M Jun ’26 Sep ’26: $6.5M $6.5M Sep ’26
Dec ’24: $3.2M $3.2M Dec ’24 Mar ’25: $595K $595K Mar ’25 Jun ’25: $5.1M $5.1M Jun ’25 Sep ’25: $5.8M $5.8M Sep ’25 Dec ’25: $5.6M $5.6M Dec ’25 Mar ’26: $7.9M $7.9M Mar ’26 Jun ’26: $5.8M $5.8M Jun ’26 Sep ’26: $6.9M $6.9M Sep ’26
Not reported for this period.
From IRMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.
Next report
Feb 9
2027 · Time not announced
Consensus EPS forecast
$0.55
$25.4M revenue est.
Year-ago EPS
$0.54
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…
Fund sentiment · Q3 2026
Neutral
Strongly bearish Neutral Strongly bullish
● 102 buying vs 97 selling ▼ Held by funds -1.1 pts ● Funds holding +1 ▲ Superinvestors: 3 added, 1 cut ● Put/call not meaningful Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Funds holding Held by funds %
Q3 2026 This quarter Last quarter Change Funds holding 214 213 +0.5% In funds' top 10 2 2 0.0% Held by funds 61.5% 62.6% −1.1 pts New / increased 28 / 74 17 / 97 −10.5% Reduced / sold out 72 / 25 61 / 29 +7.8% Put/call ratio – – –
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far. See IRMD institutional ownership →
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IRMD is in one of them and how their past IRMD trades turned out.
IRMD in the AI portfolios
Loading…
StreetAlpha hasn't covered IRMD in an article yet. Here's the latest on the wider market.
macro news Monday, November 16, 2026
Morgan Stanley Goes Maximum Overweight on Global Equities
Morgan Stanley moves to maximum overweight on global stocks, setting an 8,700 S&P 500 target on cheaper valuations and earnings growth.
StreetAlpha Macro Desk · 3 min read
macro news Friday, November 13, 2026
Fed Cuts Are Off the Table as Hot CPI Puts a December Hike in Play
Core CPI ran 0.3% in October, cuts are off the table, and a December hike is priced at 100%. Here is how vol desks read the setup.
StreetAlpha Options Desk · 3 min read
macro news Wednesday, November 11, 2026
Goolsbee Calls October CPI 'Borderline Disturbing' as Hike Talk Builds
Goolsbee called October CPI 'borderline disturbing' as core ran 0.3% again, the two year jumped 18bps and December hike odds firmed.
StreetAlpha Earnings Desk · 2 min read
About Iradimed
IRADIMED designs, makes and sells medical devices that are safe to use during magnetic resonance imaging (MRI) scans. Its main products are MRI compatible IV infusion pumps, which deliver anesthesia and other fluids to patients during scans, and a vital signs monitoring system that moves with patients between critical care units and the MRI room. The company also sells related accessories, disposable IV tubing sets and maintenance services. Based in Orlando, Florida, it sells mainly to hospitals and acute care facilities in the United States and abroad.
Headquarters Orlando, FL
Disclaimer and risk warning. The information on this page is for informational and educational purposes only. It is not financial, investment, legal, or tax advice, and it is not a recommendation to buy or sell any security.
Stocks, options, and other securities involve risk, including the loss of some or all of your investment. Options are not suitable for all investors. Past performance does not predict future results.
Parts of this page are produced with the help of AI and may contain errors or omissions. Options flow and dark pool data are delayed and may be incomplete. Check important facts against original sources.
StreetAlpha and its operators may hold positions in securities shown here.
Do your own research and consult a licensed financial professional before making any investment decision. See our Terms of Use .